Search / Trial NCT06614426

Surgical Treatment of Peri-implantitis Defects

Launched by ABEER HAKAM · Sep 25, 2024

Trial Information

Current as of October 04, 2024

Not yet recruiting

Keywords

Description

Research design * Prospective, in which participants will be recruited and then followed up throughout a specified period of time. * Randomized, parallel designed, concurrent controlled trial with participants randomly allocated to either control or test groups. * Single-blinded as the outcome accessors will be blinded to the intervention. Materials and Methods: Patients attending Dubai Dental Hospital and requiring treatment of peri-implantitis will be invited to take part in this randomized controlled trial based on the following inclusion and exclusion criteria: Inclusion criteria: ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Aged 18 or over.
  • * Require treatment of peri-implantitis (defined as the presence of bleeding and/or suppuration on gentle probing, probing depths of ≥ 6 mm, presence of bone loss beyond crestal bone level changes resulting from initial bone remodeling).
  • * Screw retained implant crown.
  • * Good compliance and commitment to attend follow-up review appointments.
  • * Willing to provide informed consent.
  • Exclusion Criteria:
  • * History of surgical therapy of peri-implantitis.
  • * Peri-implant defects indicated for regenerative procedure (i.e. contained bony defect).
  • * Cement retained implant crown.
  • * Systemic/local antibiotics during the previous 6 months.
  • * Bone metabolic disease and/or taking medications that affect bone metabolism.
  • * History of malignancy, radiotherapy or chemotherapy.
  • * Pregnant or lactating women.
  • * Smokers

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0